Clinical Trial Update: Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring dupilumab for atopic dermatitis monitored with noninvasive imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: OptiSkin Medical | Conditions: Eczema, Atopic Dermatitis | Phase 4 | Status: UNKNOWN